Publikations

Here you will find an overview of printed scientific literature (published papers) by Borkenstein & Borkenstein. You can access the respective articles via the National Library of Medicine, Web of Science, Embase, the Cochrane Library, Google Scholar, and other search engines. A literature search (as of 2025) showed that Andreas F. Borkenstein held the role of “leading author” in 84% of his 68 publications listed in PubMed, which represents a significantly above-average value according to bibliometric analyses.
(Ref.: Perneger T.: Authorship and citation patterns of highly cited biomedical researchers: a cross-sectional study. Research Integrity and Peer Review. 2023; and Post A., Li A.Y. et al.: c-index and subindices of the h-index: New variants of the h-index to account for variations in author contribution. Cureus. 2018).

This reflects his preferred working approach: from the initial research question through study design and data collection to the analysis and writing of results, he frequently assumes a leading role and accompanies projects through all phases of scientific implementation. In summary both partners (Andreas and Eva-Maria Borkenstein) published over 75 peer reviewed publications.

Borkenstein AF, Borkenstein EM, Kolesnik A, Malyugin B. Real-World Validation of the VIVEX Formula for Vitreous Volume Estimation in Vitreoretinal Surgery: A First Clinical Case Series. Ophthalmol Ther. 2025 Dec 8. doi: 10.1007/s40123-025-01291-z. Epub ahead of print. PMID: 41361663.

•••

Borkenstein AF, Ranz L, Neuper C, Borkenstein EM, Fitzek H. Assessing Particle Release from Intraocular Lenses with a Combination of OptoFluidic Force Induction, μ-Raman and μ-FTIR. Bioengineering (Basel). 2025 Oct 22;12(11):1138. doi: 10.3390/bioengineering12111138. PMID: 41301094; PMCID: PMC12649333.

•••

Borkenstein AF, Borkenstein EM, Ranz L, Korenjak Jausnik S, Neuper C, Fitzek H. Nd:YAG Laser Induced Microfragmentation in Intraocular Lenses: A Correlative Optical and Raman Spectroscopy Study. Curr Eye Res. 2025 Oct 12:1-8. doi: 10.1080/02713683.2025.2572024. Epub ahead of print. PMID: 41077822.

•••

Borkenstein AF, Borkenstein EM. Neodymium-Doped Yttrium Aluminum Garnet (Nd:YAG) Laser-Induced Damage to Intraocular Lenses: A Systematic Review of Mechanisms, Clinical Consequences, and Preventive Strategies. Cureus. 2025 Aug 24;17(8):e90903. doi: 10.7759/cureus.90903. PMID: 40862048; PMCID: PMC12375400.

•••

Borkenstein AF, Borkenstein EM. Autorefraction Pitfalls in Extended Depth-of-Focus Pseudophakia: A Case Report. Cureus. 2025 Jul 7;17(7):e87409. doi: 10.7759/cureus.87409. PMID: 40772146; PMCID: PMC12326287.

•••

Borkenstein AF, Borkenstein EM. Intraocular lens calculation for cataract surgery in high myopia: a case report of an extreme axial eyeball length of 35.7 mm. Front Med (Lausanne). 2025 Jul 4;12:1450922. doi: 10.3389/fmed.2025.1450922. PMID: 40687709; PMCID: PMC12273509.

•••

Borkenstein AF, Borkenstein EM, Omidi P, Langenbucher A. Optical Bench Evaluation of a Novel, Hydrophobic, Acrylic, One-Piece, Polyfocal Intraocular Lens with a “Zig-Zag” L-Loop Haptic Design. Vision (Basel). 2024 Nov 14;8(4):66. doi: 10.3390/vision8040066. PMID: 39585116; PMCID: PMC11587457.

•••

Borkenstein AF, Borkenstein EM. Geometry of Modern Presbyopia-Correcting Intraocular Lenses and Changes in Haptic-Capsular Bag Behavior According to Compression and Different Well Diameters: A Bench Study Using Computed Tomography. Ophthalmol Ther. 2024 Dec;13(12):3059-3077. doi: 10.1007/s40123-024-01046-2. Epub 2024 Oct 9. PMID: 39384686; PMCID: PMC11564430.

•••

Borkenstein AF, Borkenstein EM. Examining Penetration and Residual Depth in Modern Acrylic Foldable Intraocular Lenses: A Laboratory Study Using Differential Interference Contrast Microscopy to Compare Hydrophilic and Hydrophobic Materials. Cureus. 2024 Sep 28;16(9):e70383. doi: 10.7759/cureus.70383. PMID: 39345802; PMCID: PMC11438304.

•••

Borkenstein AF, Kormilina TK, Fitzek H, Rattenberger J, Kothleitner G, Charry FEM, Borkenstein EM. Incorrectly Focused Neodymium:Yttrium-Aluminum-Garnet (Nd:YAG) Laser Beam Leads to Massive Destructive Effects in Small-Aperture (Pinhole) Intraocular Lenses. Ophthalmol Ther. 2024 Oct;13(10):2745-2758. doi: 10.1007/s40123-024-01007-9. Epub 2024 Aug 17. PMID: 39153117; PMCID: PMC11408416.

•••

Borkenstein AF, Borkenstein EM, Omidi P, Langenbucher A. Image Contrast and Spectral Transmission of Presbyopia-Correcting Intraocular Lenses: Evaluating the Impact of Nd:YAG Laser Associated Defects. Curr Eye Res. 2025 Jan;50(1):51-57. doi: 10.1080/02713683.2024.2391382. Epub 2024 Aug 14. PMID: 39139124.

•••

Borkenstein AF, Borkenstein EM, Presser A. Calculated Drug Concentrations in Currently Available Intravitreal Therapies: Determination of Dilution Factor and Deviation From Recommended Doses. Cureus. 2024 Jul 31;16(7):e65888. doi: 10.7759/cureus.65888. PMID: 39092383; PMCID: PMC11291181.

•••

Schmid R, Borkenstein AF. Optical Bench Evaluation of the Latest Refractive Enhanced Depth of Focus Intraocular Lens. Clin Ophthalmol. 2024 Jul 3;18:1921-1932. doi: 10.2147/OPTH.S469849. PMID: 38978835; PMCID: PMC11229011.

•••

Borkenstein AF, Borkenstein EM. Neodymium-doped yttrium aluminum garnet (Nd: YAG) laser treatment in ophthalmology: a review of the most common procedures Capsulotomy and Iridotomy. Lasers Med Sci. 2024 Jul 2;39(1):167. doi: 10.1007/s10103-024-04118-8. PMID: 38954050.

•••

Borkenstein AF, Borkenstein EM, Langenbucher A. A Response to: Letter to the Editor Regarding “VIVEX-A Formula for Calculating Individual Vitreous Volume: A New Approach Towards Tailored Patient Dosing Regime in Intravitreal Therapy”. Ophthalmol Ther. 2024 Aug;13(8):2287-2292. doi: 10.1007/s40123-024-00975-2. Epub 2024 Jun 10. PMID: 38856836; PMCID: PMC11246316.

•••

Borkenstein AF, Mikitisin A, Schwedt A, Borkenstein EM, Mayer J. A Novel 3D High Resolution Imaging Method Using Correlative X-Ray and Electron Microscopy to Study Neodymium-Doped Yttrium Aluminum Garnet Laser-Induced Defects in Intraocular Lenses. Ophthalmic Res. 2024;67(1):292-300. doi: 10.1159/000539243. Epub 2024 May 8. PMID: 38718759.

•••

Borkenstein AF, Borkenstein EM. Precise Posterior Nd:YAG Capsulotomy without Creating Defects is Key for Patients’ Quality of Vision. Clin Ophthalmol. 2024 Feb 5;18:361-364. doi: 10.2147/OPTH.S451238. PMID: 38343902; PMCID: PMC10854258.

•••

Yan W, Borkenstein AF, Khoramnia R, Borkenstein EM, Auffarth GU. Video analysis of optic-haptic-interaction during hydrophobic acrylic intraocular lens implantation using preloaded injectors. BMC Ophthalmol. 2023 Dec 19;23(1):515. doi: 10.1186/s12886-023-03216-5. PMID: 38115049; PMCID: PMC10729437.

•••

Borkenstein AF, Borkenstein EM, Langenbucher A. VIVEX: A Formula for Calculating Individual Vitreous Volume: A New Approach Towards Tailored Patient Dosing Regime in Intravitreal Therapy. Ophthalmol Ther. 2024 Jan;13(1):205-219. doi: 10.1007/s40123-023-00838-2. Epub 2023 Nov 8. PMID: 37938450; PMCID: PMC10776541.

•••

Borkenstein AF, Borkenstein EM. Clinical Performance of New Enhanced Monofocal Intraocular Lenses: Comparison of Hydrophobic C-loop and Hydrophilic Plate-Haptic Platform. Adv Ther. 2023 Oct;40(10):4561-4573. doi: 10.1007/s12325-023-02635-6. Epub 2023 Aug 16. PMID: 37584899; PMCID: PMC10499736.

•••

Borkenstein AF, Borkenstein EM, Omidi P, Langenbucher A. Image Contrast and Spectral Transmission in Intraocular Lenses with Nd:YAG Pits. Curr Eye Res. 2023 Oct;48(10):911-918. doi: 10.1080/02713683.2023.2229540. Epub 2023 Jun 29. PMID: 37382106.

•••

Borkenstein AF, Borkenstein EM, Mühlbacher I, Flock M. Nano-Indentation to Determine Mechanical Properties of Intraocular Lenses: Evaluating Penetration Depth, Material Stiffness, and Elastic Moduli. Ophthalmol Ther. 2023 Aug;12(4):2087-2101. doi: 10.1007/s40123-023-00728-7. Epub 2023 May 21. PMID: 37211587; PMCID: PMC10287600.

•••

Schmid R, Borkenstein AF. Enhanced Depth of Focus Intraocular Lenses: Through Focus Evaluation of Wavefront-Shaping versus Diffractive Optics. Biomed Hub. 2023 Feb 28;8(1):25-30. doi: 10.1159/000529234. PMID: 36938365; PMCID: PMC10015109.

•••

Borkenstein AF, Packard R, Dhubhghaill SN, Lockington D, Donnenfeld ED, Borkenstein EM. Clear corneal incision, an important step in modern cataract surgery: a review. Eye (Lond). 2023 Oct;37(14):2864-2876. doi: 10.1038/s41433-023-02440-z. Epub 2023 Feb 14. PMID: 36788364; PMCID: PMC10516977.

•••

Borkenstein AF, Borkenstein EM, Omidi P, Langenbucher A. Evaluating impact of Nd: YAG laser associated defects on optical quality of hydrophilic and hydrophobic intraocular lenses using visualization of light propagation and USAF test targets. BMC Ophthalmol. 2022 Dec 16;22(1):494. doi: 10.1186/s12886-022-02738-8. PMID: 36527032; PMCID: PMC9756656.

•••

Borkenstein AF, Borkenstein EM, Machado E, Fitzek H, Rattenberger J, Schennach R, Kothleitner G. Micro-Computed Tomography (µCT) as a Tool for High-Resolution 3D Imaging and Analysis of Intraocular Lenses: Feasibility and Proof of the Methodology to Evaluate YAG Pits. Ophthalmol Ther. 2023 Feb;12(1):447-457. doi: 10.1007/s40123-022-00622-8. Epub 2022 Dec 9. PMID: 36481844; PMCID: PMC9834457.

•••

Schmid R, Luedtke H, Borkenstein AF. Effect of decentration and tilt on four novel extended range of vision intraocular lenses regarding far distance. Eur J Ophthalmol. 2022 Sep 26:11206721221128864. doi: 10.1177/11206721221128864. Epub ahead of print. PMID: 36163687.

•••

Schmid R, Fuchs C, Luedtke H, Borkenstein AF. Depth of focus of four novel extended range of vision intraocular lenses. Eur J Ophthalmol. 2023 Jan;33(1):257-261. doi: 10.1177/11206721221125081. Epub 2022 Sep 13. PMID: 36112834.

•••

Borkenstein AF, Borkenstein EM, Schmid R. Analysis of a novel hydrophobic acrylic enhanced monofocal intraocular lens compared to its standard monofocal type on the optical bench. BMC Ophthalmol. 2022 Sep 3;22(1):356. doi: 10.1186/s12886-022-02584-8. PMID: 36057556; PMCID: PMC9440489.

•••

Borkenstein AF, Borkenstein EM, Schmid R. Evaluating Optical Quality of a New Hydrophilic Enhanced Monofocal Intraocular Lens and Comparison to the Monofocal Counterpart: An Optical Bench Analysis. Ophthalmol Ther. 2022 Dec;11(6):2045-2056. doi: 10.1007/s40123-022-00561-4. Epub 2022 Aug 30. PMID: 36040648; PMCID: PMC9587156.

•••

Borkenstein AF, Borkenstein EM, Augustin AJ. Implantable vision-enhancing devices and postoperative rehabilitation in advanced age-related macular degeneration. Eye (Lond). 2023 Mar;37(4):597-606. doi: 10.1038/s41433-022-02179-z. Epub 2022 Jul 22. PMID: 35869389; PMCID: PMC9998400.

•••

Schmid R, Luedtke H, Borkenstein AF. Enhanced Depth-of-focus Intraocular Lenses: Latest Wavefront-shaped Optics versus Diffractive Optics. Optom Vis Sci. 2022 Apr 1;99(4):335-341. doi: 10.1097/OPX.0000000000001894. PMID: 35383733.

•••

Borkenstein AF, Borkenstein EM, Murphy K, Primo SA. Testing Activities of Daily Living (ADL) in Patients with Age-Related Macular Degeneration Undergoing Cataract Surgery: Lessons Learned from the Past and Development of a New Quality of Life (QOL) Test. Clin Ophthalmol. 2022 Feb 11;16:385-387. doi: 10.2147/OPTH.S356423. PMID: 35185330; PMCID: PMC8847117.

•••

Borkenstein AF, Borkenstein EM, Luedtke H, Schmid R. Impact of Decentration and Tilt on Spherical, Aberration Correcting, and Specific Aspherical Intraocular Lenses: An Optical Bench Analysis. Ophthalmic Res. 2022;65(4):425-436. doi: 10.1159/000522510. Epub 2022 Feb 10. PMID: 35144263.

•••

Borkenstein AF, Borkenstein EM. Geometry of Acrylic, Hydrophobic IOLs and Changes in Haptic-Capsular Bag Relationship According to Compression and Different Well Diameters: A Bench Study Using Computed Tomography. Ophthalmol Ther. 2022 Apr;11(2):711-727. doi: 10.1007/s40123-022-00469-z. Epub 2022 Feb 5. PMID: 35122227; PMCID: PMC8927568.

•••

Borkenstein AF, Borkenstein EM, Luedtke H, Schmid R. Optical Bench Analysis of 2 Depth of Focus Intraocular Lenses. Biomed Hub. 2021 Sep 27;6(3):77-85. doi: 10.1159/000519139. PMID: 34950668; PMCID: PMC8613612.

•••

Borkenstein AF, Borkenstein EM. Efficacy of Large Optic Intraocular Lenses in Myopic Eyes with Posterior Segment Pathology. Ophthalmol Ther. 2022 Feb;11(1):443-452. doi: 10.1007/s40123-021-00433-3. Epub 2021 Nov 27. PMID: 34843086; PMCID: PMC8770767.

•••

Borkenstein AF, Borkenstein EM, Malyugin B. Removing residual cortical material during cataract surgery: Visco polishing and the grindstone effect as a new surgical technique. Eur J Ophthalmol. 2022 May;32(3):1817-1820. doi: 10.1177/11206721211059909. Epub 2021 Nov 9. PMID: 34751047.

•••

Borkenstein AF, Borkenstein EM, Malyugin B. Ophthalmic Viscosurgical Devices (OVDs) in Challenging Cases: a Review. Ophthalmol Ther. 2021 Dec;10(4):831-843. doi: 10.1007/s40123-021-00403-9. Epub 2021 Oct 6. PMID: 34617249; PMCID: PMC8589875.

•••

Borkenstein AF, Borkenstein EM, Persson S, Muus G, Nielsen NV. Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL). Clin Ophthalmol. 2021 Aug 10;15:3333-3339. doi: 10.2147/OPTH.S327274. PMID: 34408391; PMCID: PMC8364374.

•••

Schmid R, Borkenstein AF. Analysis of higher order aberrations in recently developed wavefront-shaped IOLs. Graefes Arch Clin Exp Ophthalmol. 2022 Feb;260(2):609-620. doi: 10.1007/s00417-021-05362-2. Epub 2021 Aug 9. PMID: 34370067.

•••

Borkenstein AF, Borkenstein EM, Rattenberger J, Fitzek H, Langenbucher A. Comparison of Wash-out Properties after Use of the Vital Dye Trypan Blue in the Form of an Ophthalmic Dye and Bound in a Sodium Hyaluronate by Raman Spectroscopy. Curr Eye Res. 2021 Nov;46(11):1653-1658. doi: 10.1080/02713683.2021.1942075. Epub 2021 Jun 21. PMID: 34143948.

•••

Borkenstein AF, Borkenstein EM. Analysis of YAG Laser-Induced Damage in Intraocular Lenses: Characterization of Optical and Surface Properties of YAG Shots. Ophthalmic Res. 2021;64(3):417-431. doi: 10.1159/000513203. Epub 2020 Nov 20. PMID: 33221803; PMCID: PMC8259068.

•••

Ling R, Borkenstein EM, Borkenstein AF. Evaluation of Nd:YAG Laser Capsulotomy Rates in a Real-Life Population. Clin Ophthalmol. 2020 Oct 13;14:3249-3257. doi: 10.2147/OPTH.S276329. PMID: 33116375; PMCID: PMC7569058.

•••

Borkenstein AF, Borkenstein EM. Four Years of Observation to Evaluate Autonomy and Quality of Life after Implantation of a High-Add Intraocular Lens in Age-Related Macular Degeneration Patients. Case Rep Ophthalmol. 2020 Aug 7;11(2):448-456. doi: 10.1159/000508914. PMID: 32999675; PMCID: PMC7506221.

•••

Borkenstein AF, Borkenstein EM. Creating Hybrid Monovision with 7.0 mm XL Optic and High-Add AMD Intraocular Lenses (XL-MAGS) in a Patient with Retinitis Pigmentosa. Case Rep Ophthalmol. 2019 Sep 10;10(3):304-311. doi: 10.1159/000503093. PMID: 31762761; PMCID: PMC6873079.

•••

Borkenstein AF, Borkenstein EM. A case report detailing use of a new intraocular lens with advanced technology, designed specifically for patients with center-involving macular disorders. Medicine (Baltimore). 2019 Jul;98(30):e16583. doi: 10.1097/MD.0000000000016583. PMID: 31348295; PMCID: PMC6709155.

•••

Borkenstein AF, Borkenstein EM. Polarized glasses may help in symptomatic cases of intraocular lens glistenings. Clin Optom (Auckl). 2019 May 6;11:57-62. doi: 10.2147/OPTO.S202796. PMID: 31191065; PMCID: PMC6511652.

•••

Borkenstein AF, Borkenstein EM. Evaluation of a Novel Blue-Colored Ophthalmic Viscoelastic Device Applied during Phacoemulsification in Eyes with Pseudoexfoliation Syndrome. Case Rep Ophthalmol. 2019 Mar 21;10(1):101-109. doi: 10.1159/000499339. PMID: 31097951; PMCID: PMC6489075.

•••

Borkenstein AF, Borkenstein EM. Sicherheit geht vor – Evaluation von IOL-Injektorsystemen [Safety First – Evaluation of IOL Injector Systems]. Klin Monbl Augenheilkd. 2019 Aug;236(8):976-982. German. doi: 10.1055/a-0867-9853. Epub 2019 Apr 2. PMID: 30939621.

•••

Borkenstein AF, Borkenstein EM. Surgical experience with a redesigned, fully preloaded, hydrophobic acrylic intraocular lens in challenging cases of pseudoexfoliation syndrome, phacodonesis, and small pupils. Clin Ophthalmol. 2019 Jan 22;13:199-206. doi: 10.2147/OPTH.S194420. PMID: 30774299; PMCID:
PMC6348969.

•••

Borkenstein AF, Borkenstein EM. Cataract surgery with implantation of a high-add intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery. Clin Case Rep. 2018 Nov 13;7(1):74-78. doi: 10.1002/ccr3.1912. PMID: 30656012; PMCID: PMC6332778.

•••

Borkenstein AF, Borkenstein EM. Long-term clinical results and scanning electron microscopic analysis of the aspheric, hydrophobic, acrylic intraocular lens CT LUCIA 611P(Y). Clin Ophthalmol. 2018 Jul 5;12:1219-1227. doi: 10.2147/OPTH.S167895. PMID: 30013315; PMCID: PMC6038869.

•••

Borkenstein AF, Borkenstein EM. „The Big Five“ – Kataraktchirurgie bei multiplen okulären Komorbiditäten: individuelle Vorgehensweise zur Komplikationsvermeidung [“The Big Five” – Cataract Surgery Under Multiple Ocular Comorbidity: Customised Approach to Prevent Complications]. Klin Monbl Augenheilkd. 2018 Aug;235(8):894-897. German. doi: 10.1055/a-0621-9361. Epub 2018 Jun 29. PMID: 29959762.

•••

Borkenstein AF, Borkenstein EM. Patient and Surgeon Satisfaction Levels after Using an Acrylic, Hydrophobic, Monofocal IOL and the Malyugin Ring in Pseudoexfoliation Syndrome Patients. J Ophthalmol. 2018 May 15;2018:3843098. doi: 10.1155/2018/3843098. PMID: 29887992; PMCID: PMC5977012.

•••

Borkenstein A, Faschinger C, Maier R, Weger M, Theisl A, Demel U, Graninger W, Irene H, Mossböck G. Measurement of tumor necrosis factor-alpha, interleukin-6, Fas ligand, interleukin-1α, and interleukin-1β in the aqueous humor of patients with open angle glaucoma using multiplex bead analysis. Mol Vis. 2013 Nov 16;19:2306-11. PMID: 24265545; PMCID: PMC3834596.

•••

Ivastinovic D, Pöschl EM, Schwab C, Borkenstein A, Lackner EM, Wedrich A, Velikay-Parel M. Evolution of early changes at the vitreoretinal interface after cataract surgery determined by optical coherence tomography and ultrasonography. Am J Ophthalmol. 2013 Feb;155(2):404-5. doi: 10.1016/j.ajo.2012.10.007. PMID: 23312441.

•••

Ivastinovic D, Schwab C, Borkenstein A, Lackner EM, Wedrich A, Velikay-Parel M. Evolution of early changes at the vitreoretinal interface after cataract surgery determined by optical coherence tomography and ultrasonography. Am J Ophthalmol. 2012 Apr;153(4):705-9. doi: 10.1016/j.ajo.2011.09.009. Epub 2012 Jan 20. PMID: 22264689.

•••

Apple DJ, Escobar-Gomez M, Zaugg B, Kleinmann G, Borkenstein AF. Modern cataract surgery: unfinished business and unanswered questions. Surv Ophthalmol. 2011 Nov-Dec;56(6 Suppl):S3-53. doi: 10.1016/j.survophthal.2011.10.001. PMID: 22117905.

•••

Schwab C, Ivastinovic D, Borkenstein A, Lackner EM, Wedrich A, Velikay-Parel M. Prevalence of early and late stages of physiologic PVD in emmetropic elderly population. Acta Ophthalmol. 2012 May;90(3):e179-84. doi: 10.1111/j.1755-3768.2011.02310.x. Epub 2011 Nov 22. PMID: 22103663.

•••

Hara S, Borkenstein AF, Ehmer A, Auffarth GU. Retropupillary fixation of iris-claw intraocular lens versus transscleral suturing fixation for aphakic eyes without capsular support. J Refract Surg. 2011 Oct;27(10):729-35. doi: 10.3928/1081597X-20110623-01. Epub 2011 Jun 30. PMID: 21710953.

•••

Borkenstein AF, Hausberger S, Mayer C, Faschinger C. Transiente Myopie [Transient myopia]. Ophthalmologe. 2011 Jul;108(7):669-71. German. doi: 10.1007/s00347-011-2338-5. PMID: 21590350.

•••

Jin H, Limberger IJ, Borkenstein AF, Ehmer A, Guo H, Auffarth GU. Pseudophakic eye with obliquely crossed piggyback toric intraocular lenses. J Cataract Refract Surg. 2010 Mar;36(3):497-502. doi: 10.1016/j.jcrs.2009.07.054. PMID: 20202552.

•••

Jin H, Holzer MP, Rabsilber T, Borkenstein AF, Limberger IJ, Guo H, Auffarth GU. Intraocular lens power calculation after laser refractive surgery: corrective algorithm for corneal power estimation. J Cataract Refract Surg. 2010 Jan;36(1):87-96. doi: 10.1016/j.jcrs.2009.07.011. PMID: 20117710.

•••

Borkenstein AF, Reuland A, Limberger IJ, Rabsilber TM, Auffarth GU. Transscleral fixation of a toric intraocular lens to correct aphakic keratoplasty with high astigmatism. J Cataract Refract Surg. 2009 May;35(5):934-8. doi: 10.1016/j.jcrs.2008.10.062. PMID: 19393896.

•••

Jin H, Rabsilber T, Ehmer A, Borkenstein AF, Limberger IJ, Guo H, Auffarth GU. Comparison of ray-tracing method and thin-lens formula in intraocular lens power calculations. J Cataract Refract Surg. 2009 Apr;35(4):650-62. doi: 10.1016/j.jcrs.2008.12.015. PMID: 19304085.

•••

Sanchez MJ, Mannsfeld A, Borkenstein AF, Ehmer A, Limberger IJ, Holzer MP, Auffarth GU. Die Wellenfrontanalyse in der ophthalmologischen Diagnostik [Wavefront analysis in ophthalmologic diagnostics]. Ophthalmologe. 2008 Sep;105(9):818-24. German. doi: 10.1007/s00347-008-1822-z. PMID: 18758787.

•••

Auffarth GU, Borkenstein AF, Ehmer A, Mannsfeld A, Rabsilber TM, Holzer MP. Scheimpflug- und Topographiesysteme in der ophthalmologischen Diagnostik [Scheimpflug and topography systems in ophthalmologic diagnostics]. Ophthalmologe. 2008 Sep;105(9):810-7. German. doi: 10.1007/s00347-008-1821-0. PMID: 18751984.

•••

Assessment of a Novel Corneal-Shaping Device With Simultaneous Corneal Collagen Cross-Linking Using a Porcine Eye Model. Zhu AY, Vianna LM, Borkenstein EM, Elisseeff J, Jun AS.Cornea. 2016 Jan;35(1):114-21. doi: 10.1097/ICO.0000000000000663.PMID: 26509764

•••

Endothelial cell microRNA expression in human late-onset Fuchs’ dystrophy. Matthaei M, Hu J, Kallay L, Eberhart CG, Cursiefen C, Qian J, Lackner EM, Jun AS.Invest Ophthalmol Vis Sci. 2014 Jan 9;55(1):216-25. doi: 10.1167/iovs.13-12689.PMID: 24334445

•••

Design and analysis of keratoconus tissue microarrays. Lackner EM, Matthaei M, Meng H, Ardjomand N, Eberhart CG, Jun AS.Cornea. 2014 Jan;33(1):49-55. doi: 10.1097/ICO.0000000000000012.PMID: 24270675

•••

Endothelial cell whole genome expression analysis in a mouse model of early-onset Fuchs’ endothelial corneal dystrophy. Matthaei M, Hu J, Meng H, Lackner EM, Eberhart CG, Qian J, Hao H, Jun AS.Invest Ophthalmol Vis Sci. 2013 Mar 15;54(3):1931-40. doi: 10.1167/iovs.12-10898.PMID: 23449721

•••

Tissue microarray analysis of cyclin-dependent kinase inhibitors p21 and p16 in Fuchs dystrophy. Matthaei M, Lackner EM, Meng H, Hicks JL, Meeker AK, Eberhart CG, Jun AS.Cornea. 2013 Apr;32(4):473-8. doi: 10.1097/ICO.0b013e31826f324e.PMID: 23132454

•••

von Hippel-Lindau disease: treatment of retinal haemangioblastomas by targeted therapy with systemic bevacizumab. Wackernagel W, Lackner EM, Pilz S, Mayer C, Stepan V.Acta Ophthalmol. 2010 Nov;88(7):e271-2. doi: 10.1111/j.1755-3768.2009.01611.x.PMID: 20977691

•••

Targeting of VEGF-dependent transendothelial migration of cancer cells by bevacizumab.
Prager GW, Lackner EM, Krauth MT, Unseld M, Poettler M, Laffer S, Cerny-Reiterer S, Lamm W, Kornek GV, Binder BR, Zielinski CC, Valent P.Mol Oncol. 2010 Apr;4(2):150-60. doi: 10.1016/j.molonc.2010.01.002. Epub 2010 Jan 7.PMID: 20106729

•••

Targeting of Hsp32 in solid tumors and leukemias: a novel approach to optimize anticancer therapy.
Gleixner KV, Mayerhofer M, Vales A, Gruze A, Hörmann G, Cerny-Reiterer S, Lackner E, Hadzijusufovic E, Herrmann H, Iyer AK, Krauth MT, Pickl WF, Marian B, Panzer-Grümayer R, Sillaber C, Maeda H, Zielinski C, Valent P.